spironolactone has been researched along with methyldopa in 77 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 65 (84.42) | 18.7374 |
1990's | 1 (1.30) | 18.2507 |
2000's | 3 (3.90) | 29.6817 |
2010's | 7 (9.09) | 24.3611 |
2020's | 1 (1.30) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Naumann, G; Wedler, B; Wüstenberg, PW | 1 |
Michel, D | 1 |
Black, HR | 1 |
Oparil, S; Rick, JH | 1 |
Goedel-Meinen, L; Hall, D; Rudolph, W | 1 |
Kuchel, OG; Mahon, WA; McKenzie, JK; Ogilvie, RI | 1 |
Armbruster, H; Beckerhoff, R; Reck, G; Siegenthaler, W; Vetter, W | 1 |
Goldberg, LI | 1 |
Moses, C | 1 |
Riddiough, MA | 1 |
Friedman, A; Johnston, CI; Suthers, MB; Walter, NM | 1 |
Hutchinson, RG | 1 |
Das Gupta, V; Ghanekar, AG; Gibbs, CW | 1 |
Genest, J; Guthrie, GP; Kuchel, O | 1 |
Beilin, LJ; Ledingham, JG; Thomas, GW; Yeates, KM | 1 |
Burkett, LL; Hamilton, HE; Schwertner, H; Skrdlant, H; Wallace, JE | 1 |
Cagli, V | 1 |
Angelino, PF | 2 |
Giezendanner, L; Solheim, SB; Sundsfjord, JA | 1 |
Sternon, J | 1 |
Smith, PJ; Talbert, RL | 1 |
Kincaid-Smith, P | 1 |
Simpson, FO | 1 |
Fang, P; Kincaid-Smith, P; Laver, MC | 1 |
Perrier, CV; Sitavanc, L | 1 |
Rahn, KH | 1 |
Alexits, K; Káldor, A; Kállay, K; Sebestyén, K | 2 |
Biglieri, EG; Giebink, GS; Gotlin, RW; Katz, FH | 1 |
Cain, DR; Shapiro, SJ; Van de Velde, RL | 1 |
Alexandre, JM; Corvol, P; Ménard, J; Milliez, P | 1 |
Branche, G; Chiles, B; Garnier, C; Kilcoyne, MM; Soland, T; Thomson, GE; Williams, M | 1 |
Kilcoyne, MM | 1 |
Koch-Weser, J | 1 |
Baglin, A; Merceron, R; Milliez, P; Safar, M; Sobel, A | 1 |
Kim, KE; Onesti, G; Swartz, C | 1 |
Finnerty, FA | 2 |
Froment, A; Milon, H | 1 |
Fishback, DB | 1 |
Murphy, AV | 1 |
Isdale, JM; Katz, S; Thomson, PD | 1 |
Sova, J | 1 |
Froment, A; Froment, R; Zech, P | 1 |
Macoul, KL; Paris, GL | 1 |
Loggie, JM | 1 |
Milliez, P; Safar, M | 2 |
Baglin, A; Milliez, P; Safar, M | 1 |
Storm-Mathisen, H | 1 |
Bravo, EL; Dustan, HP; Tarazi, RC | 1 |
Lagrue, G; Milliez, P; Safar, M; Schlotterer, P | 1 |
Ashcroft, R; Eccleston, DW; Elliott, RW; Kerr, DN; Rastogi, SP; Volans, G; Webster, D | 1 |
Beckhelm, GA; Willard, PW | 1 |
Tobian, L | 1 |
Pomerantz, HZ | 1 |
Stevenson, JG; Umstead, GS | 1 |
Moyer, JH | 1 |
Halawa, B | 1 |
Weishar, C | 1 |
Moss, HB; Procci, WR | 1 |
HILDEN, T | 1 |
MIZGALA, HF | 1 |
Black, HR; Slim, HB; Thompson, PD | 1 |
Aboul-Enein, HY; Ali, I; ALOthman, ZA; Alsheetan, KM | 1 |
13 review(s) available for spironolactone and methyldopa
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Management of high blood pressure using beta-sympatholytics. Review].
Topics: Adrenergic beta-Antagonists; Clonidine; Furosemide; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Spironolactone | 1976 |
Preventing, detecting and managing adverse reactions of antihypertensive agents in the ambulant patient with essential hypertension.
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Drug Interactions; Ethacrynic Acid; Furosemide; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Prazosin; Propranolol; Reserpine; Sodium Chloride Symporter Inhibitors; Spironolactone | 1977 |
Renin and the therapy of hypertension.
Topics: Animals; Antihypertensive Agents; Cardiovascular Diseases; Clonidine; Diazoxide; Diuretics; Dogs; Female; Guanethidine; Humans; Hypertension; Male; Methyldopa; Propranolol; Renin; Reserpine; Spironolactone; Vasodilator Agents | 1976 |
Sexual dysfunction with antihypertensive and antipsychotic agents.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Antipsychotic Agents; Benzothiadiazines; Calcium Channel Blockers; Clonidine; Diuretics; Ejaculation; Female; Guanethidine; Humans; Male; Methyldopa; Orgasm; Penile Erection; Prazosin; Reserpine; Sexual Dysfunction, Physiological; Sodium Chloride Symporter Inhibitors; Spironolactone | 1986 |
Combination antihypertensive therapy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amphetamine; Antidepressive Agents; Antihypertensive Agents; Benzothiadiazines; Clonidine; Debrisoquin; Diuretics; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Monoamine Oxidase Inhibitors; Phenylbutazone; Phytotherapy; Plants, Medicinal; Potassium Chloride; Rauwolfia; Reserpine; Secologanin Tryptamine Alkaloids; Sodium Chloride Symporter Inhibitors; Spironolactone; Sympathomimetics; Triamterene | 1971 |
[Current antihypertensive drugs: mechanism of action].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Catecholamines; Central Nervous System; Clonidine; Diazoxide; Diuretics; Drug Synergism; Guanethidine; Guanidines; Humans; Hydralazine; Methyldopa; Propranolol; Reserpine; Spironolactone | 1973 |
Correlation of pathophysiology and pharmacotherapy in primary hypertension.
Topics: Blood Pressure; Cardiac Output; Cardiac Volume; Diuretics; Furosemide; Guanethidine; Heart Failure; Humans; Hypertension; Methyldopa; Norepinephrine; Plasma Volume; Propranolol; Renin; Reserpine; Spironolactone; Vascular Resistance; Vasodilator Agents | 1973 |
Hypertension in children and adolescents. II. Drug therapy.
Topics: Age Factors; Antihypertensive Agents; Blood Pressure Determination; Child; Chlorothiazide; Chronic Disease; Diazoxide; Female; Ferricyanides; Glomerulonephritis; Guanethidine; Humans; Hydralazine; Hypertension; Hypotension, Orthostatic; Methyldopa; Phenoxybenzamine; Phentolamine; Reserpine; Spironolactone | 1969 |
Drug systems approach to hypertension.
Topics: Captopril; Clonidine; Drug Combinations; Drug Therapy, Combination; Guanethidine; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Hypertension, Malignant; Methyldopa; Patient Compliance; Prazosin; Proteinuria; Renin-Angiotensin System; Reserpine; Spironolactone | 1984 |
[Treatment of arterial hypertension in elderly patients].
Topics: Age Factors; Aged; Antihypertensive Agents; Chlorpromazine; Diazoxide; Dihydralazine; Drug Therapy, Combination; Furosemide; Humans; Hydrochlorothiazide; Hypertension; Methyldopa; Middle Aged; Spironolactone | 1981 |
NEWER DRUGS IN THE TREATMENT OF HYPERTENSION.
Topics: Antihypertensive Agents; Bretylium Compounds; Chlorothiazide; Chlorthalidone; Diuretics; Drug Therapy; Essential Hypertension; Guanethidine; Hydralazine; Hypertension; Methyldopa; Pargyline; Rauwolfia; Spironolactone; Toxicology | 1965 |
Older blood pressure medications-do they still have a place?
Topics: Antihypertensive Agents; Chlorthalidone; Clonidine; Diuretics; Ethacrynic Acid; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Reserpine; Spironolactone; Vasodilator Agents | 2011 |
5 trial(s) available for spironolactone and methyldopa
Article | Year |
---|---|
A comparison between spironolactone and hydrochlorothiazide with and without alpha-methyldopa in the treatment of hypertension.
Topics: Adult; Angiotensin II; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Methyldopa; Middle Aged; Renin; Spironolactone | 1978 |
Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in pateints with essential hypertension.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Furosemide; Humans; Hypertension; Male; Methyldopa; Middle Aged; Oxprenolol; Placebos; Posture; Renin; Spironolactone; Stimulation, Chemical | 1976 |
The effect of spironolactone (Aldactone) and methyldopa in low and normal renin hypertension.
Topics: Adult; Aged; Blood Pressure; Cholesterol; Clinical Trials as Topic; Depression, Chemical; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Placebos; Potassium; Renin; Spironolactone; Time Factors; Urea; Uric Acid | 1975 |
Spironolactone and altizide in systemic hypertension: ambulatory multicenter study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Benzothiadiazines; Clonidine; Diuretics; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Multicenter Studies as Topic; Sodium Chloride Symporter Inhibitors; Spironolactone; Sulfonamides | 1990 |
A new look at the treatment of severe hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Chlorothiazide; Clinical Trials as Topic; Diazoxide; Drug Synergism; Female; Humans; Hypertension; Male; Mecamylamine; Methyldopa; Middle Aged; Placebos; Spironolactone; Thiazines; Uremia | 1973 |
59 other study(ies) available for spironolactone and methyldopa
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
[Treatment of hypertonus in diabetes mellitus].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diabetes Complications; Diabetes Mellitus; Ethacrynic Acid; Furosemide; Guanethidine; Humans; Hypertension; Methyldopa; Spironolactone; Thiazines | 1975 |
Management of hypertension.
Topics: Adrenergic alpha-Antagonists; Benzothiadiazines; Clonidine; Diuretics; Ethacrynic Acid; Furosemide; Humans; Hypertension; Methyldopa; Patient Care Planning; Patient Compliance; Propranolol; Secologanin Tryptamine Alkaloids; Sodium Chloride Symporter Inhibitors; Spironolactone; Triamterene; Trimethaphan; Vascular Resistance; Vasodilator Agents | 1977 |
Drug treatment of hypertension.
Topics: Clonidine; Diazoxide; Diuretics; Ganglionic Blockers; Guanethidine; Humans; Hydralazine; Hypertension; Mecamylamine; Methyldopa; Mineralocorticoid Receptor Antagonists; Minoxidil; Nitroprusside; Prazosin; Propranolol; Secologanin Tryptamine Alkaloids; Sodium Chloride Symporter Inhibitors; Spironolactone; Sympatholytics; Triamterene; Trimethaphan; Vasodilator Agents | 1977 |
[Guidelines for the medical management of arterial hypertension (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Diuretics; Humans; Hypertension; Methyldopa; Middle Aged; Spironolactone; Vasodilator Agents | 1978 |
Approach to drug therapy for hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Guanidines; Humans; Hydralazine; Hypertension; Methyldopa; Middle Aged; Patient Care Planning; Patient Compliance; Prazosin; Reserpine; Sodium Chloride Symporter Inhibitors; Spironolactone; Vasodilator Agents | 1979 |
Severe arterial hypertension caused by chronical abuse of a topical mineralocorticoid.
Topics: Adult; Aldosterone; Clonidine; Drug Combinations; Drug Therapy, Combination; Female; Fluprednisolone; Humans; Hypertension; Isomerism; Methyldopa; Naphazoline; Nasal Decongestants; Potassium; Renin; Spironolactone; Substance-Related Disorders; Time Factors; Triamterene | 1975 |
Current therapy of hypertension. A pharmacologic approach.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ganglionic Blockers; Guanethidine; Humans; Hypertension; Methyldopa; Monoamine Oxidase Inhibitors; Norepinephrine; Reserpine; Secologanin Tryptamine Alkaloids; Sodium Chloride Symporter Inhibitors; Spironolactone; Sympathetic Nervous System; Synaptic Transmission; Triamterene; Vasodilator Agents | 1975 |
Drug treatment of mild hypertension: adverse consequences.
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Drug Interactions; Female; Guanethidine; Humans; Hydralazine; Hypertension; Male; Methyldopa; Propranolol; Reserpine; Sodium Chloride Symporter Inhibitors; Spironolactone | 1978 |
Medical management of hypertension.
Topics: Benzothiadiazines; Diuretics; Guanethidine; Humans; Hypertension; Methyldopa; Reserpine; Sodium Chloride Symporter Inhibitors; Spironolactone; Triamterene | 1979 |
Stability of pediatric liquid dosage forms of ethacrynic acid, indomethacin, methyldopate hydrochloride, prednisone and spironolactone.
Topics: Child; Drug Compounding; Drug Stability; Ethacrynic Acid; Humans; Indomethacin; Methyldopa; Pharmaceutical Vehicles; Prednisone; Solutions; Spironolactone; Suspensions | 1978 |
Drugs for hypertension.
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Depression; Diuretics; Drug Combinations; Drug Therapy, Combination; Furosemide; Guanethidine; Humans; Hypertension; Methyldopa; Monoamine Oxidase Inhibitors; Potassium; Propranolol; Reserpine; Sodium Chloride Symporter Inhibitors; Spironolactone; Triamterene; Vasodilator Agents; Water-Electrolyte Imbalance | 1977 |
Identification of selected antihypertensive drugs by thin-layer chromatography.
Topics: Antihypertensive Agents; Chromatography, Thin Layer; Diuretics; Humans; Hydrochlorothiazide; Methyldopa; Reserpine; Sodium Chloride Symporter Inhibitors; Spironolactone; Triamterene | 1977 |
[Evaluation of the anti-hypertensive effect of spironolactone: trial of combined therapy with spironolactone and alpha-methyldopa].
Topics: Adult; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertension, Renal; Male; Methyldopa; Middle Aged; Spironolactone | 1976 |
[Therapeutic combinations, side effects and interactions of antihypertensive drugs].
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Dihydralazine; Diuretics; Drug Interactions; Drug Therapy, Combination; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Propranolol; Reserpine; Spironolactone | 1976 |
Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in patients with essential hypertension.
Topics: Humans; Hypertension; Methyldopa; Oxprenolol; Pindolol; Posture; Propranolol; Renin; Spironolactone | 1976 |
[Drug combinations in the treatment of primary arterial hypertension].
Topics: Antihypertensive Agents; Blood Volume; Cardiac Output; Diuretics; Drug Combinations; Drug Therapy, Combination; Guanethidine; Heart; Humans; Hydralazine; Hypertension; Methyldopa; Propranolol; Renin; Reserpine; Spironolactone; Vascular Resistance | 1975 |
Management of severe hypertension.
Topics: Benzothiadiazines; Blood Pressure; Clonidine; Diazoxide; Diet, Sodium-Restricted; Disseminated Intravascular Coagulation; Ethanolamines; Female; Glomerular Filtration Rate; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Pre-Eclampsia; Pregnancy; Propranolol; Renin; Sodium; Spironolactone | 1973 |
[Differential therapeutic principles in the drug therapy of high blood pressure].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Blood Pressure; Cardiac Volume; Clonidine; Diuretics; Drug Combinations; Guanethidine; Humans; Hydralazine; Hypertension; Kidney Failure, Chronic; Methyldopa; Renin; Reserpine; Sodium Chloride Symporter Inhibitors; Spironolactone; Time Factors; Triamterene | 1974 |
[The effect of alpha methyldopa and spironolactone on angiotensin sensitivity in man].
Topics: Adult; Angiotensin II; Blood Pressure; Depression, Chemical; Drug Synergism; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Renin; Spironolactone; Stimulation, Chemical | 1972 |
A kindred with familial glucocorticoid suppressible aldosteronism.
Topics: 17-Ketosteroids; Adrenocorticotropic Hormone; Adult; Aldosterone; Binding, Competitive; Child; Dexamethasone; Female; Fluorometry; Humans; Hydralazine; Hydrocortisone; Hyperaldosteronism; Male; Methyldopa; Pregnanetriol; Radioimmunoassay; Renin; Spironolactone; Tetrahydrocortisone | 1973 |
Spironolactone inclusions in an aldosteronoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Cytoplasmic Granules; Humans; Hyperaldosteronism; Inclusion Bodies; Methyldopa; Spironolactone | 1974 |
[How to advance antihypertensive therapy].
Topics: Adult; Angiotensin II; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Clonidine; Humans; Hypertension; Methyldopa; Middle Aged; Mineralocorticoid Receptor Antagonists; Prostaglandins; Renin; Spironolactone; Time Factors | 1974 |
Effect of alpha-methyldopa and of spironolactone on angiotensin responsiveness in man.
Topics: Angiotensin II; Blood Pressure; Humans; Methyldopa; Renin; Spironolactone | 1972 |
Characteristics of hypertension in the black population.
Topics: Adult; Angiotensin II; Animals; Black or African American; Cardiomegaly; Cerebrovascular Disorders; Chlorthalidone; Coronary Disease; Drug Therapy, Combination; Female; Guanethidine; Heart Ventricles; Humans; Hydralazine; Hypertension; Male; Methyldopa; Middle Aged; New York City; Rabbits; Radioimmunoassay; Renin; Sodium; Spironolactone | 1974 |
Adolescent hypertension. II. Characteristics and response to treatment.
Topics: Adolescent; Adult; Angiotensin II; Black or African American; Female; Humans; Hydralazine; Hypertension; Kidney; Latin America; Male; Mass Screening; Methyldopa; New York City; Propranolol; Radioimmunoassay; Renin; Sodium; Spironolactone | 1974 |
[Treatment of arterial hypertension with new drugs. 1. Severe arterial hypertension].
Topics: Antihypertensive Agents; Body Weight; Clonidine; Diuresis; Furosemide; Hemodynamics; Humans; Hypertension; Methyldopa; Sodium; Sodium Chloride; Spironolactone; Urea | 1972 |
Problems in therapy for the hypertensive patient.
Topics: Antihypertensive Agents; Blood Pressure; Carotid Sinus; Diuretics; Electric Stimulation; Ethacrynic Acid; Female; Furosemide; Guanethidine; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Hypertension, Malignant; Hypertension, Renal; Hypotension, Orthostatic; Male; Methyldopa; Nephrectomy; Phytotherapy; Plants, Medicinal; Posture; Rauwolfia; Spironolactone; Uremia | 1973 |
How to treat arterial hypertension.
Topics: Antihypertensive Agents; Chlorothiazide; Chlorthalidone; Cooperative Behavior; Diazoxide; Diuretics; Ethacrynic Acid; Furosemide; Guanethidine; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney; Methyldopa; Physician-Patient Relations; Reserpine; Spironolactone; Sulfonamides; Triamterene | 1973 |
[Medical treatment of arterial hypertension in adults].
Topics: Adult; Antihypertensive Agents; Clonidine; Diet, Sodium-Restricted; Guanethidine; Humans; Hydrazines; Hypertension; Male; Methyldopa; Reserpine; Spironolactone; Time Factors | 1973 |
Fluorescein circulation time and the treatment of hypertension in the aged.
Topics: Adult; Age Factors; Aged; Blood Circulation Time; Blood Pressure; Carbamates; Ethacrynic Acid; Female; Fluoresceins; Furosemide; Glomerular Filtration Rate; Guanethidine; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney Failure, Chronic; Male; Methyldopa; Middle Aged; Potassium; Reserpine; Spironolactone | 1973 |
Value and toxicity of therapy for idiopathic nephrotic syndrome in the child.
Topics: Anti-Bacterial Agents; Blood Protein Disorders; Child; Chlorothiazide; Cyclophosphamide; Diet, Sodium-Restricted; Dietary Proteins; Ethacrynic Acid; Furosemide; Glucocorticoids; Humans; Hydrochlorothiazide; Hypertension, Renal; Methyldopa; Nephrotic Syndrome; Plasma Substitutes; Rest; Serum Albumin; Spironolactone | 1973 |
Infantile polycystic disease of the kidneys.
Topics: Child, Preschool; Chlorothiazide; Female; Guanethidine; Humans; Hydralazine; Hypertension, Renal; Infant; Infant, Newborn; Kidney; Liver; Liver Cirrhosis; Male; Methyldopa; Polycystic Kidney Diseases; Propranolol; Spironolactone; Urography | 1973 |
Drugs used in the treatment of hypertension.
Topics: Administration, Oral; Antihypertensive Agents; Clonidine; Diazoxide; Diuretics; Ethacrynic Acid; Ferricyanides; Furosemide; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Nitric Oxide; Propranolol; Reserpine; Sodium Chloride Symporter Inhibitors; Spironolactone; Triamterene; Vasodilator Agents | 1973 |
[New trends in the diagnosis, prognosis and treatment of hypertension].
Topics: Dexamethasone; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Prognosis; Propranolol; Reserpine; Spironolactone | 1974 |
[Respective roles of hemodynamic or humoral factors and of hypotensive or salidiuretic drugs in the development of essential hypertension].
Topics: Adult; Chlorthalidone; Diet, Sodium-Restricted; Electrocardiography; Guanethidine; Humans; Hydrochlorothiazide; Hypertension; Hypertension, Malignant; Male; Methyldopa; Middle Aged; Prognosis; Reserpine; Sodium; Spironolactone; Sympathectomy | 1965 |
Reversible bullous retinal detachment in chronic renal disease.
Topics: Adult; Angiography; Diet; Female; Fluorescence; Humans; Hydrochlorothiazide; Hypertension, Renal; Hyponatremia; Kidney Failure, Chronic; Kidney Transplantation; Male; Methyldopa; Papilledema; Peritoneal Dialysis; Retinal Detachment; Sodium; Spironolactone; Transplantation, Homologous | 1969 |
[Hemodynamic basis of the medical treatment of arterial hypertension].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cardiac Output; Diuretics; Female; Guanethidine; Hemodynamics; Humans; Hydralazine; Hypertension; Male; Methyldopa; Spironolactone | 1971 |
[Malignant arterial hypertension. Intensive treatment by acute sodium depletion and antihypertensive agents].
Topics: Adult; Antihypertensive Agents; Body Weight; Creatinine; Diet, Sodium-Restricted; Diuretics; Female; Fundus Oculi; Furosemide; Heart Failure; Heart Function Tests; Humans; Hypertension, Malignant; Kidney Failure, Chronic; Kidney Function Tests; Male; Methyldopa; Middle Aged; Peritoneal Dialysis; Spironolactone; Uremia | 1972 |
[Antihypertensive therapy].
Topics: Adult; Antihypertensive Agents; Clonidine; Diuretics; Drug Interactions; Female; Humans; Hydralazine; Hypertension; Male; Methyldopa; Middle Aged; Phytotherapy; Plants, Medicinal; Rauwolfia; Spironolactone; Sympatholytics | 1972 |
Dependence of arterial pressure on intravascular volume in treated hypertensive patients.
Topics: Adult; Aged; Arteries; Blood Pressure; Female; Furosemide; Guanethidine; Humans; Hydrazines; Hydrochlorothiazide; Hypertension; Male; Methyldopa; Middle Aged; Plasma Volume; Propranolol; Spironolactone; Triamterene | 1972 |
[Medical treatment of arterial hypertension. Clinical study].
Topics: Adult; Antihypertensive Agents; Diuretics; Female; Guanethidine; Humans; Hydralazine; Hypertension; Male; Methyldopa; Middle Aged; Prognosis; Spironolactone | 1971 |
[Medical treatment of arterial hypertension: hemodynamic study].
Topics: Adult; Antihypertensive Agents; Cardiac Output; Chlorothiazide; Diuretics; Female; Hemodynamics; Humans; Hydralazine; Hypertension; Male; Methyldopa; Spironolactone | 1971 |
High dose frusemide in the treatment of hypertension in chronic renal insufficiency and of terminal renal failure.
Topics: Adolescent; Adult; Creatine; Creatinine; Diuresis; Female; Furosemide; Gout; Humans; Hypertension, Renal; Hypokalemia; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Methyldopa; Middle Aged; Potassium; Pyelonephritis; Sodium; Spironolactone; Urea; Uric Acid; Urine | 1971 |
Differential effect of hypotensive drugs on renal and steroid hypertensive rats.
Topics: Animals; Antihypertensive Agents; Benzothiadiazines; Bretylium Compounds; Desoxycorticosterone; Guanethidine; Hypertension; Hypertension, Renal; Mecamylamine; Methyldopa; Rats; Spironolactone | 1968 |
Modifying elevated blood pressure: a practical office approach.
Topics: Chlorothiazide; Chlorthalidone; Diuretics; Humans; Hypertension; Methyldopa; Phytotherapy; Plants, Medicinal; Rauwolfia; Spironolactone; Sympatholytics; Vasodilator Agents; Vasomotor System | 1969 |
Hypotensive drug therapy in the management of hypertension.
Topics: Antihypertensive Agents; Guanethidine; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Methyldopa; Pargyline; Reserpine; Spironolactone | 1969 |
Sexual dysfunction due to antihypertensive agents.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Female; Guanethidine; Humans; Hydralazine; Male; Methyldopa; Prazosin; Propranolol; Reserpine; Sex; Sexual Dysfunction, Physiological; Sodium Chloride Symporter Inhibitors; Spironolactone | 1984 |
Case study: drug-induced electrolyte changes.
Topics: Antihypertensive Agents; Drug Combinations; Female; Humans; Hydrochlorothiazide; Methyldopa; Middle Aged; Spironolactone; Water-Electrolyte Imbalance | 1982 |
Sexual dysfunction associated with oral antihypertensive medication: a critical survey of the literature.
Topics: Antihypertensive Agents; Clonidine; Diuretics; Erectile Dysfunction; Guanethidine; Humans; Hypertension; Male; Methyldopa; Propranolol; Reserpine; Spironolactone | 1982 |
[MEDICAL TREATMENT OF HYPERTENSION].
Topics: Antihypertensive Agents; Bretylium Compounds; Diuretics; Ganglionic Blockers; Guanethidine; Hydralazine; Hypertension; Methyldopa; Rauwolfia; Spironolactone | 1964 |
Applications of shun shell column and nanocomposite sorbent for analysis of eleven anti-hypertensive in human plasma.
Topics: Adsorption; Antihypertensive Agents; Chromatography, High Pressure Liquid; Diltiazem; Furosemide; Humans; Hydrochlorothiazide; Irbesartan; Iron; Labetalol; Limit of Detection; Losartan; Metal Nanoparticles; Methyldopa; Nanocomposites; Polyvinyl Alcohol; Prazosin; Propranolol; Reproducibility of Results; Solid Phase Microextraction; Spironolactone; Valsartan | 2020 |